Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [ACTIVE] · [BUSINESS]
2 clusters · 2 sources · 7 days · First seen · Last updated
Global regenerative medicine and stem cell market growth
Overview
The biotechnology sector, specifically regarding stem cell banking and regenerative medicine, is projected to experience significant market expansion through the 2030s.
The stem cell banking market is estimated to grow from $10 billion in 2025 to $31.58 billion by 2035, driven by advancements in cryopreservation and interest in neonatal preservation.
Concurrently, the broader regenerative medicine market is forecasted to rise from $23.9 billion in 2026 to $62.69 billion by 2031. Growth in this sector is attributed to the rise of personalized medicine and increased regulatory approvals, with oncology identified as the fastest-growing therapeutic area. While technological integrations like artificial intelligence and 3D printing offer opportunities, the industry faces challenges including high treatment costs and a lack of long-term clinical data.
Entities
Gilead Sciences, Inc. · Sarepta Therapeutics, Inc. · Novartis AG · SEMABIZ · MarketsandMarkets
Timeline
-
[BUSINESS] 2 sourcesRegenerative medicine market projected to reach $62.69 billion by 2031
The global regenerative medicine market is projected to grow from $23.9 billion in 2026 to $62.69 billion by 2031, driven by oncology advancements and personalized medicine.
-
[BUSINESS] 2 sourcesStem cell banking market projected to reach $31.58 billion by 2035
The global stem cell banking market is forecast to grow from $10 billion in 2025 to $31.58 billion by 2035, driven by advancements in regenerative medicine and cryopreservation.
Sources
dreamnews.jp · the-miyanichi.co.jp